Brad Pollock

Brad Pollock, Ph.D., is a Professor in the Department of Public Health Sciences at the University of California, Davis. His research focuses on pediatric oncology, disparities in cancer care, implementation science, and public health responses to epidemics. He has expertise in clinical trial design, telemedicine, and health policy analysis. Dr. Pollock’s work addresses gaps in cancer clinical trial enrollment, particularly among adolescents and young adults (AYAs), and evaluates healthcare access barriers.

Key areas of investigation include:

• Clinical trials for pediatric cancers and supportive care interventions
• Health disparities in oncology treatment outcomes
• Public health strategies for pandemic management (e.g., SARS-CoV-2 testing adherence)
• Telemedicine applications in underserved populations

Recent research highlights include analyzing delays in cancer diagnosis among young patients, evaluating the feasibility of multi-institutional data collection in oncology, and studying socioeconomic factors impacting metastatic bone disease survival. His work integrates epidemiological methods with implementation science to bridge research and practice.

Dr. Pollock has contributed to major initiatives like Healthy Davis Together, a community-driven pandemic control program, and led studies on medication authorization barriers in pediatric oncology. His publications span over two decades, addressing topics from burn care transfusion strategies to the oncogenic effects of topical medications.

His research emphasizes actionable solutions for improving healthcare equity, particularly in vulnerable populations such as rural children and AYA cancer patients. Collaborations include the Children’s Oncology Group, National Cancer Institute networks, and Clinical and Translational Science Award programs.